FluoretiQ announces the closure of £1.1 million funding round

By SETsquared-Bristol | 21st February 2022

Our member and University of Bristol spin-out, FluoretiQ, has today announced the completion of a £1.1 million, pre-series A investment. Their pioneering NANOPLEX technology is a 15-minute proprietary diagnostic platform for bacterial infections.   The round was led by early-stage life science investors, Deepbridge Capital LLP, with significant participation from MAINStream, OION, SAIC and existing investors. This…

Read More

FluoretiQ case study: Revolutionising bacterial diagnostics

By SETsquared-Bristol | 4th November 2021

To help our aspiring entrepreneurs and future SETsquared Bristol members, we showcase member and alumni case studies demonstrating the breadth of tech at SETsquared Bristol and what it takes to achieve success. We had a chat with FluoretiQ Co-founder and CEO, Neciah Dorh… FluoretiQ Key Facts Start date: 2 March 2017 Market sector: Healthcare (Diagnostics) Location:  Bristol Number of employees: 10…

Read More

GenomeKey case study: Saving lives through early diagnosis of sepsis

By SETsquared-Bristol | 7th July 2021

To help our aspiring entrepreneurs and future SETsquared Bristol members, we showcase member and alumni case studies demonstrating the breadth of tech at SETsquared Bristol and what it takes to achieve success. We had a chat with GenomeKey CEO, Michael Roberts… GenomeKey Facts Start date:  August 2019 Market sector: Medtech/diagnostics Location: Bristol Number of employees: 9 growing to 12 and beyond Amount…

Read More